ArticlebioRxiv : the preprint server for biology2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma.
Dhana Sekhar Reddy Bandi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.